1997
DOI: 10.1002/(sici)1097-0185(199703)247:3<405::aid-ar12>3.0.co;2-t
|View full text |Cite
|
Sign up to set email alerts
|

Distribution of endocrine cells displaying immunoreactivity for one or more peptides in the pancreas of the adult Vervet monkey (Cercopithecus aethiops)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

2
4
0

Year Published

1998
1998
2014
2014

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(6 citation statements)
references
References 24 publications
2
4
0
Order By: Relevance
“…Average number of PP-cells for each islet is 22.7 in the duodenal lobe, and 18.12 in the splenic lobe. Our results are similar to those from other researchers (Orci et al , 1976; Louw et al , 1997). …”
Section: Discussionsupporting
confidence: 93%
See 2 more Smart Citations
“…Average number of PP-cells for each islet is 22.7 in the duodenal lobe, and 18.12 in the splenic lobe. Our results are similar to those from other researchers (Orci et al , 1976; Louw et al , 1997). …”
Section: Discussionsupporting
confidence: 93%
“…The coexistence of glucagon- and PP-like immunoreactivity in endocrine pancreas cells has already been demonstrated in amphibians, mammals, and fish (Kaung and Elde, 1980; Kaung, 1985a, 1985b; Wolfe-Coote et al , 1988; Herrera et al , 1991; Lozano et al , 1991; Park and Bendayan, 1992; Louw et al , 1997), by comparing the immunolabeling for either antigen in adjacent ultrathin sections.…”
Section: Discussionmentioning
confidence: 91%
See 1 more Smart Citation
“…Previous studies have revealed coexistence of glucagon-and PP-like immunoreactivity in endocrine pancreas cells of frog, rat, baboon, murine, monkey, and fish (Kaung and Elde, 1980;Kaung, 1985aKaung, , 1985bWolfe-Coote et al, 1988;Herrera et al, 1991;Lozano et al, 1991;Park and Bendayan, 1992;Louw et al, 1997). However, those experiments were performed by staining adjacent ultrathin sections with anti-glucagon serum and anti-PP serum respectively by peroxidase antiperoxidase (PAP) or immuno-gold labeling or avidin-biotin-peroxidase method, and the situation of two kinds of positive cells were compared.…”
mentioning
confidence: 99%
“…To analyse the specificity of the antiserum employed against BDNF, which in particular shares amino acid sequences with NT4/5, it was essential to include antibody specificity dot blotting (Larsson 1981;Louw et al 1997).…”
Section: Dot Blotmentioning
confidence: 99%